Companies in
Pharmaceutical Industry

Alpha-O Peptides AG

Pharmaceutical Industry · Riehen · Since 2003

Alpha-O Peptides AG develops technologies in therapeutics and biotechnology and licenses them to qualified industry partners. The company focuses on peptide- and protein-based self-assembling nanoparticle platforms for vaccine, antigen-display and drug-delivery applications, as reflected in its patent portfolio.

Alpinamed AG

Cosmetics Industry · Freidorf Tg · Since 1983

The core activity of Alpinamed AG is the development, manufacture and distribution of pharmaceuticals, medical devices and dietary supplements based on medicinal plants and plant extracts. The company also offers contract manufacturing and services in the areas of research and development, quality assurance and manufacturing processes.

Alpine Bio GmbH

Pharmaceutical Industry · Pratteln · Since 2021

Alpine-Bio is a pharmaceutical company focused on the development and commercialization of medicines for specific indications. It utilizes data analysis to identify and evaluate new projects and opportunities. The company collaborates closely with academic institutions and other life sciences companies to develop innovative solutions for patients and healthcare professionals.

Altamira Medica AG

Medical Technology Industry · Basel · Since 2020

The core activity of Altamira Therapeutics is the development and marketing of pharmaceuticals and therapeutics, particularly in the field of RNA technology and the treatment of inner ear and nasal sinus diseases. The company focuses on developing innovative medicines and therapeutics to help patients with various health issues.

Altergon SA

Medical Technology Industry · Lugano · Since 1985

The core activity of Altergon Italia Srl Unipersonale is the development, manufacture and marketing of pharmaceutical products and medical devices, particularly: * Production of medicated plasters (cerotti medicati) and transdermal patches (patch transdermici) * Production of hydrogel products for topical and transdermal application of active ingredients * Production of hyaluronic acid products (Acido Ialuronico) for the pharmaceutical and medical industry * Development and production of biotechnological products, such as biopolymers for orthopedics and tissue engineering * Production of medical devices, such as pre-filled syringes and infusion solutions * Development and production of innovative products, such as microneedles for transdermal application of active ingredients The company also offers services such as Contract Development and Manufacturing (CDMO), where it takes over the development and production of pharmaceutical products for other companies.

Alvotech Swiss AG

Pharmaceutical Industry · Zurich · Since 2014

Alvotech Swiss AG develops and manufactures biosimilars, with a pipeline focused on monoclonal antibodies and other biologic medicines. The company follows a vertically integrated approach from R&D through drug product manufacturing and collaborates with commercial partners for market access.

Amacom GmbH

Pharmaceutical Industry · Zwingen · Since 2003

Amacom GmbH offers selected products and services and provides web offerings such as “Butler Team” and “Terra Natura”. The company website lists contact details including a phone number, email address and a contact form.

A. Menarini GmbH

Pharmaceutical Industry · Zurich · Since 1996

The core activity of A. Menarini GmbH is the development, manufacture and marketing of pharmaceuticals, particularly medications for the basic care of patients, which are mainly prescribed by general practitioners and specialists. The products cover various therapeutic areas, including cardiology, infectiology, allergology, diabetology, rheumatology/pain management and medical aesthetics.

Amicus Therapeutics Switzerland GmbH

Research & Development · Zurich · Since 2019

The core activity of Amicus Therapeutics is the development of innovative therapies for the treatment of rare genetic diseases, particularly lysosomal storage disorders such as Fabry disease and Pompe disease. The company focuses on developing "First-in-Class" treatments that represent new classes of active ingredients to treat these diseases.

Amyra Biotech AG

Research & Development · Basel · Since 2013

The core activity of AMYRA Biotech is the development and research of Brush Border Enzyme Supplementation Technology (BBEST), particularly for the treatment of general health and nutrition issues, food intolerances and gastrointestinal diseases through the supplementation of enzymes found in the small intestine mucosa.

Anaveon AG

Pharmaceutical Industry · Basel · Since 2017

Anaveon is a biotechnology company specializing in the development of pharmaceutical products, particularly immunotherapies. The company's core activity encompasses the research and development of therapeutic candidates, ranging from discovery to clinical testing. Anaveon focuses on treating immune-mediated diseases and has expertise in the areas of autoimmunity, transplantation, and inflammation.

AND Biotech AG

Pharmaceutical Industry · Basel · Since 2024

AND Biotech AG is a science-led company developing bioactive technologies that target core human resilience systems such as energy metabolism, immune regulation, cellular repair and adaptive signalling. The company translates promising compounds into clinically meaningful interventions and develops scalable technologies to address biological decline prior to disease onset.

Andreabal AG

Pharmaceutical Industry · Allschwil · Since 1988

The core activity of Andreabal AG is the development, manufacture and distribution of products for women before, during and after pregnancy, including pregnancy preparation, breastfeeding and menopause, as well as vitamins, iron deficiency and skin and nail care products.

Angelini Pharma S.p.A., Rom, Zweigniederlassung Zug

Medical Technology Industry · Zug · Since 2022

The core activity of Angelini Pharma is the development, production and marketing of pharmaceuticals, particularly in the area of the central nervous system, mental health, pain and rare diseases. The company is active in both the pharmaceutical and mass market sectors, offering both prescription and over-the-counter products.

Anikin Sàrl

Pharmaceutical Industry · Begnins · Since 2018

Anikin Sàrl designs and sells ergonomic pet-care objects and accessories such as cat litter boxes, litter scoops and raised bowl stands. The products use naturally sourced, recyclable plastic and are manufactured locally in reintegration workshops, with packaging and processes designed to minimize environmental impact.

Aphaia Pharma AG

Research & Development · Zug · Since 2024

The core activity of Aphaia Pharma AG is the development and marketing of pharmaceuticals, particularly in the fields of life sciences and biotechnology. The company focuses on the research and development of innovative therapeutics and medications, particularly in the areas of microvascular medicine and the treatment of diseases such as obesity and metabolic disorders.

apimedi GmbH

Pharmaceutical Industry · Oberhelfenschwil · Since 2005

The core activity of apimedi GmbH is commercial beekeeping, the production and distribution of bee products, such as honey, as well as the implementation of beekeeping training courses.

Apofilm SA

Pharmaceutical Industry · Morges · Since 1988

Apolab SA

Pharmaceutical Industry · Peseux · Since 2024

The core activity of Apolab is the manufacture of high-quality preparations, in particular magistral formulas and formula officinalis, ranging from simple to complex preparations, including medications, cosmetics and dietary supplements. The company produces sterile and non-sterile preparations in small quantities and also offers individually tailored preparations upon request.

Apotheke Roter Ochsen AG

Pharmacies & Drugstores · Glarus · Since 2019

The core activity of Formula Labor is the manufacture of special recipes and medicines, in particular pharmaceuticals that are no longer available on the market. This includes both sterile and non-sterile productions, as well as analytics and the creation of study samples. The company offers contract manufacturing services for pharmacies, medical practices and clinics, and has a wide range of active and auxiliary substances in GMP-tested pharmaceutical quality.

Apricot Therapeutics AG

Pharmaceutical Industry · Zurich · Since 2022

The core activity of Apricot BIO is the development and application of Drug Response Profiling for Systems Medicine, particularly in the field of cancer treatment. This involves researching and analyzing the deep molecular phenotyping of individual cells in response to anti-cancer drugs, enabling personalized treatment recommendations.

APTISSEN SA

Research & Development · Plan-Les-Ouates · Since 2013

Aptissen develops and distributes medical products, particularly orthobiological solutions for the treatment of muscle and joint pain. The company's core activities include research, development and marketing of products such as Synolis VA and Cartylis, which are used for tissue regeneration and repair.

Arakena Pharmaceuticals AG

Pharmaceutical Industry · Basel · Since 2024

Arakena Pharmaceuticals AG focuses on discovering and developing GRK5 inhibitors as a first‑in‑class treatment for acute and chronic cardiomyopathies, including Takotsubo cardiomyopathy. The company in‑licenses mid‑stage discovery compounds and develops drug‑like, GRK‑selective inhibitors, applying AI‑assisted decision tools and university‑licensed intellectual property to advance preclinical and clinical development.

Arela AG

Licensing & Marketing of Intellectual Property · Schaffhausen · Since 2010

The core activity of ARELA is to offer pharmaceutical products and services from selected partners in Asia, Europe and Latin America, particularly in the fields of ophthalmology and oncology. ARELA acts as a reliable partner and gateway for these products and services in selected markets, such as Korea, Japan, Europe and Latin America.

argento com GmbH

Pharmaceutical Industry · Kreuzlingen · Since 2007

The core activity of Argento com is the development, manufacture and marketing of medical products, dietary supplements and pharmaceuticals, as well as the provision of health services. The company focuses on improving the health and quality of life of people.

argenx Switzerland SA

Pharmaceutical Industry · Châtelaine · Since 2020

argenx Switzerland SA is a biopharmaceutical company that discovers, develops and commercializes antibody-based therapies for severe autoimmune diseases. Its portfolio includes the FcRn-targeting agent efgartigimod (marketed as VYVGART and VYVGART Hytrulo), a pipeline of additional antibody candidates such as empasiprubart, and ongoing clinical research.

Asceneuron SA

Pharmaceutical Industry · Eysins · Since 2012

The core activity of Asceneuron SA is the development of innovative small molecules and Tau modifiers for the treatment of diseases, particularly in the area of the central nervous system (CNS). The company focuses on the early stages of drug development and conducts clinical trials to test the efficacy and safety of its active ingredients.

Aschem GmbH

Pharmaceutical Industry · Allschwil · Since 2018

The core activity of ASCHEM GmbH is the development, synthesis and marketing of various chemical building blocks for drug development and production, as well as the provision of services in the field of nanotechnology, including the development of nano-based drug formulations and targeted drug delivery systems.

ASSOCIAZIONE ALAN GHITIS per la Lotta contro il Cancro

Pharmaceutical Industry · Paradiso · Since 2019

The company's core activity is the development of personalized oncological treatments through the application of artificial intelligence, machine learning and structure-based drug design, with the goal of developing effective therapies for cancer patients.

Astellas Pharma AG

Pharmaceutical Industry · Wallisellen · Since 1987

The core activity of Astellas Pharma AG is the development, manufacture and marketing of pharmaceuticals, particularly in the therapeutic areas of oncology, urology, nephrology and transplantation. The company is also engaged in research and development of new medicines and supports medical training and clinical studies.

ASTRA Therapeutics AG

Pharmaceutical Industry · Villigen · Since 2019

The core activity of ASTRA Therapeutics is the development of precision-crafted medicines to combat eukaryotic pathogens, particularly protozoa that cause infections in humans, animals and plants. The company focuses on developing therapeutics that target the microtubular cytoskeleton structure of pathogens to prevent the spread of diseases.

Athebio AG

Research & Development · Schlieren · Since 2019

The core activity of Athebio AG is the development and provision of proprietary technology for the creation of targeted therapeutics with improved efficacy and safety, particularly through the use of "plug & play" DARPin technology (Athebody). The company focuses on partnering with pharmaceutical companies to develop and market innovative medicines.

Atopia Therapeutics SA

Pharmaceutical Industry · Geneva · Since 2016

Atopia Therapeutics SA is developing a disease‑modifying therapy for asthma and other allergic diseases. Its lead candidate, ATP‑R13, is a patented recombinant protein derived from a Helicobacter pylori molecule intended for oral administration to modulate immune tolerance and reduce inflammation; the company holds an exclusive worldwide licence from the University of Zurich and is conducting IND‑enabling activities.

Atreon SA

Pharmaceutical Industry · Pully · Since 2021

Atreon SA develops AI-driven digital health solutions, including digital biomarkers and mobile and web platforms for remote monitoring of musculoskeletal and chronic pain conditions. The company collaborates with academic partners on patient-centric design, algorithm development, data safety and real-world evidence generation.

Aurealis Therapeutics AG

Pharmaceutical Industry · Zug · Since 2018

The core activity of Aurealis Therapeutics is the development and marketing of bacteria-based cell and gene therapies for the treatment of chronic wounds and cancer. In particular, the company focuses on the development of proprietary technologies that use genetically modified Lactococcus cremoris bacteria to produce multiple human therapeutic proteins. The company's two leading clinical products are AUP-16 for chronic wounds and AUP-55 for cancer.

Autolus Switzerland AG

Research & Development · Basel · Since 2023

Autolus Switzerland AG develops advanced autologous CAR T cell therapies for patients with cancer and autoimmune diseases, applying chimeric antigen receptors, advanced cell programming and T cell manufacturing. The company advances clinical‑stage programs for hematological and solid tumor indications, including the obe‑cel candidate for B‑cell acute lymphoblastic leukemia.

Avosano Industrie Service AG

Pharmaceutical Industry · Niederbipp · Since 2024

Avosano Industrie Service AG is a specialist provider of pharmaceutical logistics and supply-chain services. It handles storage, processing and distribution of medicines and offers complementary services such as order entry, customer service, accounts receivable management, emergency deliveries, quality control and secondary packaging.

Avrion Therapeutics SA

Research & Development · Lausanne · Since 2020

The core activity of Avrion Tx is the development of gene therapies, particularly for the treatment of rare diseases and specific forms of blindness.

Axalbion SA

Research & Development · Lausanne · Since 2021

Axalbion SA is a clinical-stage biopharmaceutical company developing TRPM8 agonists. Its lead candidate AX-8 is being developed for topical treatment of refractory chronic cough and dry eye syndrome.

AxCellerate Sagl

Pharmaceutical Industry · Agno · Since 2023

AxCellerate Sagl provides contract research services based on a proprietary platform that integrates microelectrode arrays (MEAs) and glass microfluidics to study 3D neuronal models for disease modeling, target validation, and preclinical efficacy and safety testing.

Azafaros Switzerland AG

Pharmaceutical Industry · Basel · Since 2020

The company's core activity is the development and marketing of pharmaceuticals, particularly in the field of rare diseases and oncology. The company is involved in clinical development, regulatory affairs and the distribution of medicines, as well as strategic planning and management of business relationships in the pharmaceutical industry.

AZAD Pharma AG

Pharmaceutical Industry · Schaffhausen · Since 2003

The core activity of AZAD is the development and manufacturing of generic active pharmaceutical ingredients (APIs) and finished products for the pharmaceutical industry.

Baccinex S.A.

Pharmaceutical Industry · Courroux · Since 1999

Adragos Pharma is a contract development and manufacturing organization (CDMO) for pharmaceutical products. The company's core activity encompasses the development, manufacture and analysis of (bio)pharmaceutical products, including sterile and non-sterile liquids, semi-solids, tablets and suppositories. The company also offers services such as inspection, packaging, storage and distribution of pharmaceutical products.

Bailleul (Suisse) SA

Pharmaceutical Industry · Geneva · Since 2014

Bailleul (Suisse) SA is a pharmaceutical company specializing in the development and commercialization of medicinal products, dietary supplements and dermo‑cosmetic products.

Baliopharm AG

Pharmaceutical Industry · Reinach Bl · Since 2007

Baliopharm AG is a biotechnology company developing antibody therapeutics for chronic liver diseases, immune-mediated inflammatory diseases and oncology. Its portfolio includes monoclonal antibodies and antibody-derived formats such as monovalent and bispecific constructs designed for targeted selectivity.

Basilea Pharmaceutica International AG, Allschwil

Pharmaceutical Industry · Allschwil · Since 2008

Basilea Pharmaceutica International AG, Allschwil develops and commercializes pharmaceutical products focused on anti-infectives, particularly antifungal and antibiotic therapies. The company’s portfolio includes Cresemba (isavuconazole) and Zevtera (ceftobiprole), and it maintains clinical and preclinical programs for additional anti-infective candidates.

Basilea Pharmaceutica AG, Allschwil

Pharmaceutical Industry · Allschwil · Since 2002

Basilea Pharmaceutica AG, Allschwil is a pharmaceutical company that develops and commercializes medicines for severe and life‑threatening bacterial and fungal infections. Its portfolio includes antifungal and antibacterial products such as Cresemba (isavuconazole) and Zevtera.